STK11IP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.602400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.970820E-01
Normal-vs-Stage2
8.079800E-02
Normal-vs-Stage3
1.030190E-01
Normal-vs-Stage4
3.025200E-01
Stage1-vs-Stage2
8.502600E-01
Stage1-vs-Stage3
3.202400E-01
Stage1-vs-Stage4
6.869600E-01
Stage2-vs-Stage3
1.385030E-01
Stage2-vs-Stage4
7.608600E-01
Stage3-vs-Stage4
1.812030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.979600E-02
Normal-vs-AfricanAmerican
1.855980E-01
Normal-vs-Asian
5.175400E-01
Caucasian-vs-AfricanAmerican
8.589400E-01
Caucasian-vs-Asian
1.547560E-01
AfricanAmerican-vs-Asian
3.742600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.698370E-01
Normal-vs-Female
4.045600E-02
Male-vs-Female
1.807150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.586800E-01
Normal-vs-Age(41-60Yrs)
1.087010E-01
Normal-vs-Age(61-80Yrs)
1.069820E-01
Normal-vs-Age(81-100Yrs)
7.049800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.511000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.976200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.090600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.102200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.385600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.571400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.431790E-02
Normal-vs-Daily Drinker
1.625840E-01
Normal-vs-Weekly Drinker
2.278200E-01
Normal-vs-Occasional Drinker
5.818800E-01
Normal-vs-Social Drinker
5.962400E-02
Non Drinker-vs-Daily Drinker
4.692300E-02
Non Drinker-vs-Weekly Drinker
1.332560E-01
Non Drinker-vs-Occasional Drinker
2.997900E-03
Non Drinker-vs-Social Drinker
4.518800E-01
Daily Drinker-vs-Weekly Drinker
8.996000E-01
Daily Drinker-vs-Occasional Drinker
2.112600E-01
Daily Drinker-vs-Social Drinker
3.183400E-01
Weekly Drinker-vs-Occasional Drinker
2.626200E-01
Weekly Drinker-vs-Social Drinker
4.783600E-01
Occasional Drinker-vs-Social Drinker
5.688200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.350010E-01
Normal-vs-Grade 2
3.092000E-02
Normal-vs-Grade 3
1.646460E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.513600E-01
Grade 1-vs-Grade 3
9.476800E-01
Grade 1-vs-Grade 4
1.350010E-01
Grade 2-vs-Grade 3
6.763800E-01
Grade 2-vs-Grade 4
3.092000E-02
Grade 3-vs-Grade 4
1.646460E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.042000E-02
Normal-vs-NonDiabetic
1.314790E-01
Diabetic-vs-NonDiabetic
4.699800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.445630E-01
Normal-vs-NoPancreatitis
1.129790E-01
Pancreatitis-vs-NoPancreatitis
6.104600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.885380E-01
Normal-vs-N1
5.168000E-02
N0-vs-N1
2.154600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.152800E-01
Normal-vs-TP53-NonMutant
2.240200E-01
TP53-Mutant-vs-TP53-NonMutant
9.366000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
